Bill

Bill > S3394


NJ S3394

NJ S3394
Authorizes medical cannabis for treatment of sickle cell anemia.


summary

Introduced
12/15/2022
In Committee
12/15/2022
Crossed Over
Passed
Dead
01/08/2024

Introduced Session

2022-2023 Regular Session

Bill Summary

This bill expands the list of medical conditions that qualify a patient for the medical use of cannabis to include sickle cell anemia. Sickle cell anemia is an inherited blood disorder characterized primarily by chronic anemia and periodic episodes of pain. The medical use of cannabis can treat or alleviate the pain or other symptoms associated with certain medical conditions.

AI Summary

This bill expands the list of medical conditions that qualify a patient for the medical use of cannabis to include sickle cell anemia. Sickle cell anemia is an inherited blood disorder characterized primarily by chronic anemia and periodic episodes of pain, and the medical use of cannabis can treat or alleviate the pain or other symptoms associated with this condition.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (on 12/15/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...